236 related articles for article (PubMed ID: 27388475)
1. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study.
Sun L; Liang L; Gao X; Zhang H; Yao P; Hu Y; Ma Y; Wang F; Jin Q; Li H; Li R; Liu Y; Hu FB; Zeng R; Lin X; Wu J
Diabetes Care; 2016 Sep; 39(9):1563-70. PubMed ID: 27388475
[TBL] [Abstract][Full Text] [Related]
2. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose.
Merino J; Leong A; Liu CT; Porneala B; Walford GA; von Grotthuss M; Wang TJ; Flannick J; Dupuis J; Levy D; Gerszten RE; Florez JC; Meigs JB
Diabetologia; 2018 Jun; 61(6):1315-1324. PubMed ID: 29626220
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.
Mihalik SJ; Goodpaster BH; Kelley DE; Chace DH; Vockley J; Toledo FG; DeLany JP
Obesity (Silver Spring); 2010 Sep; 18(9):1695-700. PubMed ID: 20111019
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort.
Owei I; Umekwe N; Stentz F; Wan J; Dagogo-Jack S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1698-1705. PubMed ID: 33926260
[TBL] [Abstract][Full Text] [Related]
6. Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.
Wang F; Sun L; Sun Q; Liang L; Gao X; Li R; Pan A; Li H; Deng Y; Hu FB; Wu J; Zeng R; Lin X
Clin J Am Soc Nephrol; 2018 Apr; 13(4):560-568. PubMed ID: 29519950
[TBL] [Abstract][Full Text] [Related]
7. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
[TBL] [Abstract][Full Text] [Related]
8. Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population.
Gunther SH; Khoo CM; Tai ES; Sim X; Kovalik JP; Ching J; Lee JJ; van Dam RM
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33004401
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics in diabetes, a review.
Pallares-Méndez R; Aguilar-Salinas CA; Cruz-Bautista I; Del Bosque-Plata L
Ann Med; 2016; 48(1-2):89-102. PubMed ID: 26883715
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
11. A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease.
Chang Y; Gao XQ; Shen N; He J; Fan X; Chen K; Lin XH; Li HM; Tian FS; Li H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7433-7441. PubMed ID: 32706083
[TBL] [Abstract][Full Text] [Related]
12. Size and shape of the associations of glucose, HbA
Ruijgrok C; Dekker JM; Beulens JW; Brouwer IA; Coupé VMH; Heymans MW; Sijtsma FPC; Mela DJ; Zock PL; Olthof MR; Alssema M
Diabetologia; 2018 Jan; 61(1):93-100. PubMed ID: 29018885
[TBL] [Abstract][Full Text] [Related]
13. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) study.
Papandreou C; Bulló M; Ruiz-Canela M; Dennis C; Deik A; Wang D; Guasch-Ferré M; Yu E; Razquin C; Corella D; Estruch R; Ros E; Fitó M; Fiol M; Liang L; Hernández-Alonso P; Clish CB; Martínez-González MA; Hu FB; Salas-Salvadó J
Am J Clin Nutr; 2019 Mar; 109(3):626-634. PubMed ID: 30796776
[TBL] [Abstract][Full Text] [Related]
15. Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes.
Bouchouirab FZ; Fortin M; Noll C; Dubé J; Carpentier AC
Can J Diabetes; 2018 Aug; 42(4):382-388.e1. PubMed ID: 29129455
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis.
Jabbar Al-Rikabi SA; Etemadi A; Morad MM; Nowrouzi A; Panahi GS; Mondeali M; Toorani-Ghazvini M; Nasli-Esfahani E; Razi F; Bandarian F
Endocrinol Diabetes Metab; 2024 May; 7(3):e00484. PubMed ID: 38739122
[TBL] [Abstract][Full Text] [Related]
17. Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance.
Nowak C; Hetty S; Salihovic S; Castillejo-Lopez C; Ganna A; Cook NL; Broeckling CD; Prenni JE; Shen X; Giedraitis V; Ärnlöv J; Lind L; Berne C; Sundström J; Fall T; Ingelsson E
Sci Rep; 2018 Jun; 8(1):8691. PubMed ID: 29875472
[TBL] [Abstract][Full Text] [Related]
18. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
19. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
Kolberg JA; Jørgensen T; Gerwien RW; Hamren S; McKenna MP; Moler E; Rowe MW; Urdea MS; Xu XM; Hansen T; Pedersen O; Borch-Johnsen K
Diabetes Care; 2009 Jul; 32(7):1207-12. PubMed ID: 19564473
[TBL] [Abstract][Full Text] [Related]
20. Plasma acylcarnitine levels increase with healthy aging.
Jarrell ZR; Smith MR; Hu X; Orr M; Liu KH; Quyyumi AA; Jones DP; Go YM
Aging (Albany NY); 2020 Jun; 12(13):13555-13570. PubMed ID: 32554854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
